Search research articles
Contact Us
Filters
Showing results (41-50 of 253) with videos related to
Page
of 26
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
October 9, 2007
Statins--treatment option for central nervous system autoimmune disease?
Martin S Weber, Lawrence Steinman, Scott S Zamvil
Cold Spring Harbor Perspectives in Medicine
|
January 24, 2018
B-Cell Therapies in Multiple Sclerosis
Joseph J Sabatino, Scott S Zamvil, Stephen L Hauser
Nature Reviews. Neuroscience
|
November 28, 2019
Publisher Correction: B cells in autoimmune and neurodegenerative central nervous system diseases
Joseph J Sabatino, Anne-Katrin Pröbstel, Scott S Zamvil
Current Opinion in Neurology
|
July 15, 2003
Statins as potential therapeutic agents in neuroinflammatory disorders
Olaf Stüve, Sawsan Youssef, Lawrence Steinman, et al.
Nature Reviews. Neuroscience
|
November 13, 2019
B cells in autoimmune and neurodegenerative central nervous system diseases
Joseph J Sabatino, Anne-Katrin Pröbstel, Scott S Zamvil
The Neurologist
|
December 20, 2007
The immunogenicity of disease-modifying therapies for multiple sclerosis: clinical implications for neurologists
Edward J Fox, Timothy K Vartanian, Scott S Zamvil
Revue Neurologique
|
November 11, 1998
Pathogenesis and treatment of central nervous system demyelinating disease
S S Zamvil, J M Soos, H L Weiner
Current Opinion in Immunology
|
August 26, 2025
B-cell antigen presentation in central nervous system autoimmunity
Carson E Moseley, Joseph J Sabatino, Scott S Zamvil
Experimental Neurology
|
April 16, 2014
Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis
Michel Varrin-Doyer, Scott S Zamvil, Ulf Schulze-Topphoff
Journal of Neuroscience Methods
|
September 2, 2003
Efficient technique for immortalization of murine microglial cells relevant for studies in murine models of multiple sclerosis
Julie K Olson, Scott S Zamvil, Stephen D Miller
Page
of 26
Search research articles
Search
Showing results (41-50 of 253) with videos related to
Sort By:
Page
of 26
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
October 9, 2007
Statins--treatment option for central nervous system autoimmune disease?
Martin S Weber, Lawrence Steinman, Scott S Zamvil
Cold Spring Harbor Perspectives in Medicine
|
January 24, 2018
B-Cell Therapies in Multiple Sclerosis
Joseph J Sabatino, Scott S Zamvil, Stephen L Hauser
Nature Reviews. Neuroscience
|
November 28, 2019
Publisher Correction: B cells in autoimmune and neurodegenerative central nervous system diseases
Joseph J Sabatino, Anne-Katrin Pröbstel, Scott S Zamvil
Current Opinion in Neurology
|
July 15, 2003
Statins as potential therapeutic agents in neuroinflammatory disorders
Olaf Stüve, Sawsan Youssef, Lawrence Steinman, et al.
Nature Reviews. Neuroscience
|
November 13, 2019
B cells in autoimmune and neurodegenerative central nervous system diseases
Joseph J Sabatino, Anne-Katrin Pröbstel, Scott S Zamvil
The Neurologist
|
December 20, 2007
The immunogenicity of disease-modifying therapies for multiple sclerosis: clinical implications for neurologists
Edward J Fox, Timothy K Vartanian, Scott S Zamvil
Revue Neurologique
|
November 11, 1998
Pathogenesis and treatment of central nervous system demyelinating disease
S S Zamvil, J M Soos, H L Weiner
Current Opinion in Immunology
|
August 26, 2025
B-cell antigen presentation in central nervous system autoimmunity
Carson E Moseley, Joseph J Sabatino, Scott S Zamvil
Experimental Neurology
|
April 16, 2014
Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis
Michel Varrin-Doyer, Scott S Zamvil, Ulf Schulze-Topphoff
Journal of Neuroscience Methods
|
September 2, 2003
Efficient technique for immortalization of murine microglial cells relevant for studies in murine models of multiple sclerosis
Julie K Olson, Scott S Zamvil, Stephen D Miller
Page
of 26